Vivos Therapeutics names Roman Franklin CFO as Bradford Amman resigns
VVOS•CFO transition
Vivos Therapeutics named Roman Franklin, 42, as chief financial officer, effective July 31, 2026.
Bradford Amman resigned as CFO and secretary on July 31, 2026; the exit was described as voluntary with no disputes cited.
Amman will support the handover for 90 days as a non-executive transition employee, then advise for 180 days as an independent contractor.
